Article Information
History
- August 23, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Liwei Wang, MD, PhD1,*,
- Andrew Wen, MS1,*,
- Sunyang Fu, PhD1,
- Xiaoyang Ruan, PhD1,
- Ming Huang, PhD1,
- Rui Li, PhD1,
- Qiuhao Lu, PhD1,
- Andrew E Williams, PhD2,3 and
- Hongfang Liu, PhD1
- 1McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA
- 2Clinical and Translational Science Institute Tufts Medical Center Boston US
- 3Institute for Clinical Research and Health Policy Studies Tufts Medical Center Boston US
- ↵*Corresponding author:
Hongfang Liu, PhD, Postal address: 7000 Fannin Street #Suite 600, Houston, TX 77030 E-mail: hongfang.liu{at}uth.tmc.edu, Telephone: 713-500-3900
Liwei Wang and Andrew Wen contribute equally.
Posted August 23, 2024.
Adoption of the OMOP CDM for Cancer Research using Real-world Data: Current Status and Opportunities
